Direktorat Registrasi ObatValid

ALPRAZOLAM

BPOM Number: GPL2658403610B1
Approved: 21 June 2026
Expiry: 20 June 2031
Form: Tablet

About This Registration

ALPRAZOLAM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GPL2658403610B1. Its current registration status is Valid, with the licence valid until 20 June 2031. The product is registered to EMDI MELIA PHARMA - INDONESIA. BPOM first approved this registration in June 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 22 June 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 10 STRIP @ 10 TABLET
Department: Direktorat Registrasi Obat
Data Last Updated: 22 June 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

EMDI MELIA PHARMA - INDONESIA
KAB. SUMEDANG
NPWP: 314383639446000
owner
View profile →

Manufacturing Sites

EMDI MELIA PHARMA - INDONESIA
KAB. SUMEDANG
primary
View profile →

Ingredients (1)

ALPRAZOLAM

Market Intelligence

Owner Portfolio: EMDI MELIA PHARMA - INDONESIA holds 52 BPOM registrations
Manufacturer Scale: EMDI MELIA PHARMA - INDONESIA produces 52 registered products
Registration Age: Registered for 3 months

Is this your product?